Leucine-rich repeat kinase 2-related functions in GLIA: an update of the last years
- PMID: 33960369
- DOI: 10.1042/BST20201092
Leucine-rich repeat kinase 2-related functions in GLIA: an update of the last years
Abstract
Missense mutations in the leucine-rich repeat kinase-2 (LRRK2) gene represent the most common cause of autosomal dominant Parkinson's disease (PD). In the years LRRK2 has been associated with several organelles and related pathways in cell. However, despite the significant amount of research done in the past decade, the contribution of LRRK2 mutations to PD pathogenesis remains unknown. Growing evidence highlights that LRRK2 controls multiple processes in brain immune cells, microglia and astrocytes, and suggests that deregulated LRRK2 activity in these cells, due to gene mutation, might be directly associated with pathological mechanisms underlying PD. In this brief review, we recapitulate and update the last LRRK2 functions dissected in microglia and astrocytes. Moreover, we discuss how dysfunctions of LRRK2-related pathways may impact glia physiology and their cross-talk with neurons, thus leading to neurodegeneration and progression of PD.
Keywords: LRRK2; Parkinson's disease; astrocytes; glia; microglia.
© 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.
Similar articles
-
Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance.Mol Neurobiol. 2021 Jul;58(7):3119-3140. doi: 10.1007/s12035-021-02327-8. Epub 2021 Feb 24. Mol Neurobiol. 2021. PMID: 33629273 Free PMC article.
-
Microglia and astrocyte dysfunction in parkinson's disease.Neurobiol Dis. 2020 Oct;144:105028. doi: 10.1016/j.nbd.2020.105028. Epub 2020 Jul 28. Neurobiol Dis. 2020. PMID: 32736085 Free PMC article. Review.
-
Cross-talk between LRRK2 and PKA: implication for Parkinson's disease?Biochem Soc Trans. 2017 Feb 8;45(1):261-267. doi: 10.1042/BST20160396. Biochem Soc Trans. 2017. PMID: 28202680 Review.
-
From structure to ætiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson's disease.Biochem J. 2021 Jul 30;478(14):2945-2951. doi: 10.1042/BCJ20210383. Biochem J. 2021. PMID: 34328508 Free PMC article.
-
Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.Adv Neurobiol. 2017;14:3-30. doi: 10.1007/978-3-319-49969-7_1. Adv Neurobiol. 2017. PMID: 28353276 Review.
Cited by
-
Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils.Acta Neuropathol Commun. 2025 May 12;13(1):98. doi: 10.1186/s40478-025-02015-x. Acta Neuropathol Commun. 2025. PMID: 40355981 Free PMC article.
-
Leucine-Rich Repeat Kinase-2 Controls the Differentiation and Maturation of Oligodendrocytes in Mice and Zebrafish.Biomolecules. 2024 Jul 19;14(7):870. doi: 10.3390/biom14070870. Biomolecules. 2024. PMID: 39062584 Free PMC article.
-
Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson's Disease.Genes (Basel). 2022 Oct 25;13(11):1937. doi: 10.3390/genes13111937. Genes (Basel). 2022. PMID: 36360174 Free PMC article. Review.
-
LRRK2 Kinase Inhibition Attenuates Astrocytic Activation in Response to Amyloid β1-42 Fibrils.Biomolecules. 2023 Feb 6;13(2):307. doi: 10.3390/biom13020307. Biomolecules. 2023. PMID: 36830676 Free PMC article.
-
The immune system in Parkinson's disease: what we know so far.Brain. 2024 Oct 3;147(10):3306-3324. doi: 10.1093/brain/awae177. Brain. 2024. PMID: 38833182 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous